Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DRORDror Ortho-Design, Inc.

OTC · CIK 0001282980
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3843 Dental Equipment & Supplies
FY end1231
XBRL facts223

Identity from submissions API

NameDror Ortho-Design, Inc.
CIK0001282980
TickersDROR
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3843 Dental Equipment & Supplies
EIN850461778
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone724-206-1500
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • NOVINT TECHNOLOGIES INC (2004-03-05T05:00:00.000Z → 2023-08-14T04:00:00.000Z)
Business address
480 JOHNSON ROAD
SUITE 200
WASHINGTON
PA
15301
PA
Mailing address
480 JOHNSON ROAD
SUITE 200
WASHINGTON
PA
15301
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

249 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q QUARTERLY REPORT 0001213900-26-120701 000-51783 261561762 34 3102515 1 1
2026-10-29 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-113884 000-51783 261502667 34 691780 1 1
2026-09-25 8-K CURRENT REPORT 5.07 0001213900-26-103238 000-51783 261406290 34 183609 1 1
2026-09-16 S-1/A AMENDMENT NO. 4 TO FORM S-1 0001213900-26-100567 333-287624 261384475 33 8439816 1 1
2026-09-09 DEF 14A PROXY STATEMENT 0001213900-26-098221 000-51783 261366706 34 1975357
2026-08-28 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-26-095155 000-51783 261341250 34 806588
2026-08-19 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-091749 000-51783 261296201 34 672324 1 1
2026-07-30 10-Q QUARTERLY REPORT 0001213900-26-083423 000-51783 261224481 34 2912481 1 1
2026-06-05 3 xslF345X06/ownership.xml 0001213900-26-065884 3307
2026-05-13 10-Q QUARTERLY REPORT 0001213900-26-055852 000-51783 26973920 34 2886294 1 1
2026-05-01 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-050937 000-51783 26932424 34 693938 1 1
2026-04-01 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-26-037951 333-287624 26824599 33 8198877 1 1
2026-03-04 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-023642 000-51783 26721145 34 720862 1 1
2026-02-27 10-K ANNUAL REPORT 0001213900-26-021201 000-51783 26694503 34 6904461 1 1
2026-02-03 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-26-010996 333-287624 26589907 33 8202651 1 1
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-004298 005-80763 26580087 34 9866
2026-01-06 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-26-001784 000-51783 26511415 34 778113 1 1
2025-12-08 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-119227 000-51783 251556138 34 682319 1 1
2025-11-18 10-Q QUARTERLY REPORT 0001213900-25-112153 000-51783 251495384 34 3863209 1 1
2025-11-17 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-111229 000-51783 251489221 34 18172
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076768 000-51783 251220576 34 3130851 1 1
2025-07-23 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-067007 000-51783 251143579 34 904371 1 1
2025-07-14 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-063798 333-287624 251122480 33 6716987 1 1
2025-06-25 8-K CURRENT REPORT 5.07 0001213900-25-057787 000-51783 251073688 34 182851 1 1
2025-06-20 DEFR14A DEFINITIVE PROXY STATEMENT 0001213900-25-056176 000-51783 251061320 34 378161
2025-06-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-055956 005-80763 251059802 34 6910
2025-06-20 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-055867 005-80763 251059350 34 9032
2025-06-18 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-055378 000-51783 251055098 34 683009 1 1
2025-06-10 8-K CURRENT REPORT 8.01 0001213900-25-053169 000-51783 251038144 34 180280 1 1
2025-06-10 PRER14A PRELIMINARY PROXY STATEMENT 0001213900-25-053165 000-51783 251038126 34 614122
2025-06-05 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-051592 000-51783 251027529 34 758169 1 1
2025-05-28 S-1 REGISTRATION STATEMENT 0001213900-25-048332 333-287624 25996376 33 6678832 1 1
2025-05-21 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-046195 000-51783 25970845 34 1141993
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044120 000-51783 25952108 34 2704332 1 1
2025-04-10 DRS filename1.htm 0001213900-25-030681 377-07879 25828858 33 1348781
2025-02-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-008200 005-80763 25662976 34 9900
2025-02-19 10-K ANNUAL REPORT 0001213900-25-015289 000-51783 25639901 34 6148733 1 1
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098394 000-51783 241461576 34 3117673 1 1
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-069044 000-51783 241208116 34 2637511 1 1
2024-06-25 4 xslF345X05/ownership.xml 0001213900-24-055839 5532
2024-06-25 4 xslF345X05/ownership.xml 0001213900-24-055836 5657
2024-06-25 4 xslF345X05/ownership.xml 0001213900-24-055833 5662
2024-06-25 4 xslF345X05/ownership.xml 0001213900-24-055829 5457
2024-06-17 424B3 PROSPECTUS 0001213900-24-053390 333-276981 241049215 33 1690201
2024-06-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-14 16:00:00 9999999995-24-001851 333-276981 241046840 33 1882
2024-06-12 CORRESP filename1.htm 0001213900-24-052005 6497
2024-06-05 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-24-050050 333-276981 241022023 33 6449612 1 1
2024-05-20 10-Q QUARTERLY REPORT 0001213900-24-045144 000-51783 24964211 34 2444504 1 1
2024-05-15 NT 10-Q FORM NT 10-Q 0001213900-24-043649 000-51783 24951315 34 29622
2024-05-10 CORRESP filename1.htm 0001213900-24-041797 53827
2024-05-03 UPLOAD filename1.pdf 0000000000-24-005055 333-276981 45266
2024-04-25 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-24-036233 000-51783 24876831 34 291906 1 1
2024-04-17 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-033845 333-276981 24851730 33 5441281 1 1
2024-04-17 CORRESP filename1.htm 0001213900-24-033826 27552
2024-04-01 10-K ANNUAL REPORT 0001213900-24-028793 000-51783 24810026 34 5457544 1 1
2024-03-05 UPLOAD filename1.pdf 0000000000-24-002465 333-276981 53482
2024-02-09 S-1 REGISTRATION STATEMENT 0001999371-24-001801 333-276981 24615514 33 7529948 1 1
2024-01-10 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-24-002609 005-80763 24525988 34 48266
2024-01-04 8-K CURRENT REPORT 3.03,5.02,5.03,5.07,9.01 0001999371-24-000104 000-51783 24512682 34 486356 1 1
2023-12-18 ARS ANNUAL REPORT TO SECURITY HOLDERS 0001999371-23-001051 000-51783 231493853 34 239387
2023-12-18 DEF 14A DEFINITIVE PROXY STATEMENT 0001999371-23-001049 000-51783 231493763 34 1426665
2023-12-08 PRE 14A PRELIMINARY PROXY STATEMENT 0001999371-23-000903 000-51783 231476145 34 1427646
2023-11-20 10-Q QUARTERLY REPORT 0001999371-23-000407 000-51783 231423729 34 2523624 1 1
2023-11-14 NT 10-Q NOTIFICATION OF LATE FILING 0001999371-23-000203 000-51783 231405790 34 22845
2023-11-14 8-K CURRENT REPORT 5.03,9.01 0001999371-23-000202 000-51783 231405740 34 206007 1 1
2023-11-14 8-K/A AMENDMENT TO FORM 8-K 5.03,9.01 0001999371-23-000201 000-51783 231405694 34 418575 1 1
2023-10-24 8-K CURRENT REPORT 4.01,9.01 0001387131-23-012626 000-51783 231342994 34 222163 1 1
2023-09-27 4 xslF345X05/haddad-form4_091323.xml 0001387131-23-011683 8382
2023-09-27 4 xslF345X05/hurvitz_form4-092723.xml 0001387131-23-011682 10081
2023-09-27 4 xslF345X05/ravad_form4-092723.xml 0001387131-23-011681 9421
2023-09-27 4 xslF345X05/shvets_form4-092723.xml 0001387131-23-011680 9442
2023-09-27 3 xslF345X02/haddad_form3-092723.xml 0001387131-23-011679 3030
2023-09-27 3 xslF345X02/ravad_form3-092723.xml 0001387131-23-011678 2997
2023-09-27 3 xslF345X02/shvets_form3-092723.xml 0001387131-23-011677 3025
2023-09-27 3 xslF345X02/englander_form3-092723.xml 0001387131-23-011676 3016
2023-09-20 SC 13G formsc13g.htm 0001493152-23-033205 005-80763 231266894 34 117182
2023-09-18 D xslFormDX01/primary_doc.xml 06b 0001387131-23-011288 021-492369 231261590 33 9472
2023-09-18 8-K CURRENT REPORT 1.01,3.02 0001387131-23-011287 000-51783 231261586 34 194075 1 1
2023-08-18 8-K/A AMENDMENT TO FORM 8-K 9.01 0001839882-23-021700 000-51783 231186321 34 270907 1 1
2023-08-14 8-K CURRENT REPORT 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,9.01 0001387131-23-009791 000-51783 231171837 34 6012936
2023-08-14 10-Q QUARTERLY REPORT 0001387131-23-009779 000-51783 231171353 34 2169461 1 1
2023-07-11 8-K CURRENT REPORT 1.01,9.01 0001387131-23-008364 000-51783 231081248 34 586417 1 1
2023-06-23 SC 13G/A AMENDMENT NO.2 TO SCHEDULE 13G 0001213900-23-051156 005-80763 231035180 34 48683
2023-05-12 10-Q QUARTERLY REPORT 0001387131-23-006462 000-51783 23915871 34 1472585 1 1
2023-03-31 10-K ANNUAL REPORT 0001839882-23-008634 000-51783 23788888 34 2062737 1 1
2022-11-14 10-Q QUARTERLY REPORT 0001387131-22-011403 000-51783 221386778 34 1566351 1 1
2022-08-12 10-Q QUARTERLY REPORT 0001387131-22-008713 000-51783 221160311 34 1566601 1 1
2022-05-13 10-Q QUARTERLY REPORT 0001387131-22-006134 000-51783 22923706 34 1522583 1 1
2022-03-23 10-K ANNUAL REPORT 0001387131-22-003894 000-51783 22763973 34 1776561 1 1
2022-01-31 SC 13G/A AMENDMENT NO.1 TO SCHEDULE 13G 0001213900-22-004586 005-80763 22575153 34 49080
2021-11-12 10-Q QUARTERLY REPORT 0001387131-21-011017 000-51783 211403381 34 1596873 1 1
2021-08-12 10-Q QUARTERLY REPORT 0001387131-21-008428 000-51783 211168722 34 1504956 1 1
2021-05-21 10-Q QUARTERLY REPORT 0001387131-21-005971 000-51783 21948877 34 1017603 1
2021-05-17 NT 10-Q NOTICE OF INABILITY TO TIMELY FILE 0001387131-21-005688 000-51783 21926474 34 19674
2021-03-24 SC 13G SCHEDULE 13G 0001213900-21-017488 005-80763 21767697 34 40954
2021-03-24 10-K ANNUAL REPORT 0001387131-21-003819 000-51783 21766427 34 1367122 1
2020-11-13 10-Q QUARTERLY REPORT 0001387131-20-009881 000-51783 201310969 34 1218810 1
2020-08-14 10-Q QUARTERLY REPORT 0001387131-20-007507 000-51783 201103467 34 1096300 1
2020-06-02 SC 13D SCHEDULE 13D 0001213900-20-013912 005-80763 20936882 34 43843
2020-06-02 SC 13D SCHEDULE 13D 0001213900-20-013874 005-80763 20935783 34 49440
2020-05-28 SC 13D SCHEDULE 13D 0001213900-20-013577 005-80763 20918882 34 34232
2020-05-26 3 xslF345X02/ownership.xml 0001213900-20-013425 5905
2020-05-26 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-20-013415 005-80763 20908451 34 28648
2020-05-26 3 xslF345X02/ownership.xml 0001213900-20-013405 3520
2020-05-21 3 xslF345X02/ownership.xml 0001213900-20-013199 4592
2020-05-21 3 xslF345X02/ownership.xml 0001213900-20-013197 4540
2020-05-14 10-Q QUARTERLY REPORT 0001387131-20-004779 000-51783 20879084 34 1216864 1
2020-05-07 10-K ANNUAL REPORT 0001387131-20-004506 000-51783 20854158 34 1300366 1
2020-02-12 SEC STAFF ACTION filename1.pdf 9999999997-20-000652 4006
2020-02-10 CORRESP filename1.htm 0001387131-20-001264 12834
2020-01-23 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES 0001387131-20-000419 000-51783 20539726 34 1937424
2020-01-23 RW REGISTRATION WITHDRAWAL REQUEST 0001387131-20-000418 000-51783 20539723 NE 12701
2020-01-22 10-12G/A AMENDMENT TO FORM 10-12G 0001387131-20-000382 000-51783 20537442 34 1937418
2020-01-21 CORRESP filename1.htm 0001387131-20-000383 22979
2020-01-07 RW REGISTRATION WITHDRAWAL REQUEST 0001387131-20-000114 000-51783 20512865 NE 13335
2019-12-06 UPLOAD filename1.pdf 0000000000-19-016176 46444
2019-11-14 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES 0001387131-19-008752 000-51783 191221787 34 854614
2011-12-22 15-12G FORM 15 0001193125-11-350612 000-51783 111277403 34 12345
2011-10-28 8-K rrd324523.htm 5.02 0001181431-11-053722 000-51783 111164779 34 14126
2011-07-07 SC 13D v228005_sc13d.htm 0001144204-11-039533 005-80763 11955756 34 47249
2011-06-23 4 PRIMARY DOCUMENT 0001352429-11-000001 7125
2011-05-25 3 PRIMARY DOCUMENT 0001520257-11-000001 10341
2011-05-25 3 PRIMARY DOCUMENT 0001518284-11-000001 10321
2011-05-19 3 PRIMARY DOCUMENT 0001521108-11-000001 3433
2011-05-18 D xslFormDX01/primary_doc.xml 06 0001388169-11-000001 021-160024 11855435 33 11621
2011-05-11 3 PRIMARY DOCUMENT 0001520093-11-000001 3411
2011-04-11 8-K CURRENT REPORT 1.01,2.01,3.02,5.02,5.03,8.01,9.01 0001144204-11-021212 000-51783 11751843 34 712264
2011-02-08 UPLOAD filename1.pdf 0000000000-11-008164 46029
2011-01-25 CORRESP filename1.htm 0001144204-11-004052 26846
2011-01-10 UPLOAD filename1.pdf 0000000000-11-001847 54497
2010-12-08 CORRESP filename1.htm 0001144204-10-065384 2067213
2010-11-19 CORRESP filename1.htm 0001144204-10-062292 13512
2010-11-04 UPLOAD filename1.pdf 0000000000-10-065874 51017
2010-10-19 CORRESP filename1.htm 0001144204-10-054413 45389
2010-10-06 UPLOAD filename1.pdf 0000000000-10-059077 58545
2010-08-31 CORRESP filename1.htm 0001144204-10-047525 471443
2010-08-19 UPLOAD filename1.pdf 0000000000-10-047535 60077
2010-03-15 SC 13G nvnt13g030810.htm 0000909450-10-000035 005-80763 10679399 34 35706
2010-02-11 SC 13G/A v173710_sc13ga.htm 0001144204-10-006630 005-80763 10589913 34 296264
2010-02-02 SC 13G nvnt13g123109.htm 0000909450-10-000019 005-80763 10564985 34 35768
2009-11-23 10-Q v167365_10q.htm 0001144204-09-061549 000-51783 091202382 34 660835
2009-11-16 NT 10-Q v165872_nt10q.txt 0001144204-09-059507 000-51783 091185014 34 6415
2009-08-19 10-Q v158460_10q.htm 0001144204-09-044631 000-51783 091024071 34 712341
2009-08-14 NT 10-Q v157892_nt10-q.txt 0001144204-09-043697 000-51783 091016135 34 6524
2009-05-15 10-Q v149690_10q.htm 0001144204-09-027400 000-51783 09832411 34 736643
2009-04-23 10-K/A v146949_10ka.htm 0001144204-09-022021 000-51783 09766423 34 2124869
2009-04-16 10-K v146269_10k.htm 0001144204-09-020859 000-51783 09752181 34 2535294
2009-03-31 NT 10-K v144799_nt-10k.txt 0001144204-09-017551 000-51783 09717572 34 6571
2009-02-17 SC 13G/A rabsc13ga_novint-123108.htm 0000912282-09-000189 005-80763 09609103 34 77979
2009-02-13 SC 13G/A v139839_sc13g.htm 0001144204-09-007669 005-80763 09597571 34 313840
2009-02-13 SC 13G nvnt13g123108.htm 0000909450-09-000038 005-80763 09597357 34 35715
2008-12-22 D xslFormDX01/primary_doc.xml 06 0001447169-08-000002 021-63528 081264581 33 9297
2008-12-09 8-K v134381_8k.htm 1.01,2.03,3.02,9.01 0001144204-08-068453 000-51783 081237926 34 450559
2008-11-19 10-Q v132139_10-q.htm 0001144204-08-065520 000-51783 081200755 34 667821
2008-11-14 NT 10-Q v132377_nt10q.txt 0001144204-08-064055 000-51783 081189329 34 7750
2008-08-14 10-Q v123534_10q.htm 0001144204-08-046986 000-51783 081017489 34 638181
2008-06-17 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-029019 021-63528 08052654 34 1711
2008-06-16 DEF 14A v117240_def14a.htm 0001144204-08-035315 000-51783 08900584 34 488386
2008-06-13 8-K v117234_8-k.htm 1.01,2.03,3.02,9.01 0001144204-08-035053 000-51783 08897895 34 348786
2008-06-05 4/A PRIMARY DOCUMENT 0001423051-08-000004 7183
2008-05-23 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-026153 021-63528 08047987 34 1711
2008-05-19 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-025331 021-63528 08050357 34 1711
2008-05-15 10-Q v114498_10q.htm 0001144204-08-029604 000-51783 08837470 34 628344
2008-05-12 8-K v113642_8k.htm 1.01,2.03,3.02,9.01 0001144204-08-027848 000-51783 08824662 34 353086
2008-04-30 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-08-022331 021-63528 08045703 34 1711
2008-04-15 8-K v110797_8k.htm 1.01,2.03,3.02,9.01 0001144204-08-022653 000-51783 08758199 34 349161
2008-04-09 10KSB v109745_10ksb.htm 0001144204-08-021377 000-51783 08747355 34 1897296
2008-04-01 NT 10-K v109231_nt10k.txt 0001144204-08-019547 000-51783 08727271 34 7739
2008-03-13 8-K v106851_8-k.htm 8.01 0001144204-08-014970 000-51783 08685601 34 33043
2008-03-03 SC 13G SCHEDULE 13G 0001169232-08-001192 005-80763 08658852 34 9345
2008-02-11 SC 13G/A v100792_sc13g.htm 0001144204-08-007282 005-80763 08591015 34 192346
2008-02-07 SC 13G/A rabsc13ga_novint-12312007.htm 0000912282-08-000143 005-80763 08585869 34 31199
2007-11-16 424B3 v094718_424b3.htm 0001144204-07-062511 333-115548 071252394 33 481615
2007-11-16 424B3 v094717_424b3.htm 0001144204-07-062508 333-143234 071252385 33 481739
2007-11-15 10QSB v094239_10qsb.htm 0001144204-07-062163 000-51783 071249386 34 626206
2007-11-15 NT 10-Q v094406_nt10-q.htm 0001144204-07-061855 000-51783 071247323 34 42929
2007-10-25 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-046143 021-63528 07081490 34 1711
2007-08-15 424B3 424B3 0000950134-07-018327 333-143234 071059321 33 170876
2007-08-15 424B3 424B3 0000950134-07-018326 333-115548 071059318 33 171039
2007-08-14 10QSB FORM 10-QSB 0001362310-07-001858 000-51783 071056098 34 229443
2007-08-13 424B3 PROSPECTUS 0000950134-07-017921 333-115548 071046565 33 739361
2007-08-10 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0000950134-07-017400,2007-08-10 9999999995-07-003239 333-115548 071046992 33 2100
2007-08-09 10KSB/A AMENDMENT TO FORM 10-KSB 0000950134-07-017402 000-51783 071037596 34 583725
2007-08-09 POS AM POST-EFFECTIVE AMENDMENT TO FORM SB-2 0000950134-07-017400 333-115548 071037589 33 888868
2007-08-08 CORRESP filename1.htm 0000950134-07-017390 11673
2007-08-03 UPLOAD COMMENT LETTER DATED AUGUST 3, 2007 | POS AM NO. 1 TO FORM SB-2 (333-115548) | S 0000000000-07-038044 39517
2007-07-27 POS AM POST-EFFECTIVE AMENDMENT TO FORM SB-2 0000950134-07-016105 333-115548 071007602 33 1787531
2007-07-23 8-K FORM 8-K 1.01,8.01,9.01 0000950134-07-015627 000-51783 07993386 34 88415
2007-06-27 S-8 FORM S-8 0000950134-07-014201 333-144104 07944510 33 116664
2007-06-21 3 xslF345X02/d07-72230_ex.xml 0001169232-07-002734 5027
2007-06-21 8-K FORM 8-K 8.01,9.01 0000950134-07-013817 000-51783 07934213 34 18738
2007-06-19 424B3 424B3 0000950134-07-013626 333-143234 07928154 33 802117
2007-06-18 EFFECT xslEFFECTX01/primary_doc.xml SB-2,,2007-06-18 16:30:00 9999999995-07-002442 333-143234 07927234 33 2087
2007-05-24 SB-2 FORM SB-2 0000950134-07-012297 333-143234 07877378 33 1045642
2007-05-21 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-027760 021-63528 07054958 34 1717
2007-05-21 4 PRIMARY DOCUMENT 0001388169-07-000016 8940
2007-05-15 10QSB FORM 10QSB 0001362310-07-000856 000-51783 07853046 34 269660
2007-05-14 DEF 14A DEFINITIVE PROXY STATEMENT 0000950134-07-011390 000-51783 07845762 34 189120
2007-04-30 PRE 14A PRELIMINARY PROXY STATEMENT 0000950134-07-009560 000-51783 07801619 34 188906
2007-04-30 4 PRIMARY DOCUMENT 0001388169-07-000014 5045
2007-04-26 SC 13G p75612_13g5.htm 0000914760-07-000074 005-80763 07791644 34 148817
2007-04-16 4 PRIMARY DOCUMENT 0001388169-07-000013 8177
2007-04-06 PRER14C REVISED PRE 14C 0000950134-07-007676 000-51783 07753233 34 183320
2007-04-05 4 PRIMARY DOCUMENT 0001376641-07-000001 7350
2007-04-02 10KSB FORM 10-KSB 0000950134-07-007228 000-51783 07737082 34 590032
2007-03-19 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-013432 021-63528 07047869 34 1711
2007-03-19 4 PRIMARY DOCUMENT 0001352429-07-000002 7432
2007-03-19 PRE 14C PRELIMINARY INFORMATION STATEMENT 0000950150-07-000011 000-51783 07704411 34 179556
2007-03-09 8-K FORM 8-K 1.01,3.02,8.01,9.01 0000950137-07-003531 000-51783 07682314 34 300649
2007-03-01 8-K FORM 8-K 3.03,5.03,9.01 0000950124-07-001232 000-51783 07663755 34 33942
2007-02-20 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-07-007273 021-63528 07043694 34 1717
2007-02-08 SC 13G/A rabsc13ga_novtech-12312006.htm 0000912282-07-000167 005-80763 07593296 34 30942
2006-12-20 8-K FORM 8-K 1.01,9.01 0000950124-06-007725 000-51783 061290691 34 128050
2006-11-20 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-06-047838 021-63528 06063301 34 1717
2006-11-17 10QSB FORM 10-QSB 0000950137-06-012622 000-51783 061227395 34 262472
2006-11-14 NT 10-Q FORM 12B-25 0000950124-06-006894 000-51783 061214409 34 23485
2006-09-27 3 PRIMARY DOCUMENT 0001376641-06-000002 3910
2006-09-22 8-K FORM 8-K 1.01,5.02,9.01 0000950124-06-005456 000-51783 061103944 34 27111
2006-08-21 10QSB FORM 10-QSB 0000950124-06-004710 000-51783 061045481 34 267944
2006-08-14 NT 10-Q FORM NT 10-Q 0000950124-06-004530 000-51783 061029301 34 14738
2006-06-01 424B3 NOVING TECHNOLOGIES, INC. - 333-115548 0000950129-06-005955 333-115548 06878017 33 194091
2006-05-22 10QSB NOVINT TECHNOLOGIES, INC.- MARCH 31, 2006 0000950129-06-005743 000-51783 06858141 34 345402
2006-05-15 NT 10-Q NOVINT TECHNOLOGIES, INC. - 3/31/2006 0000950129-06-005486 000-51783 06838146 34 14331
2006-04-17 10KSB NOVINT TECHNOLOGIES, INC.- DECEMBER 31, 2005 0000950129-06-003996 000-51783 06761247 34 825144
2006-03-31 NT 10-K NOVINT TECHNOLOGIES, INC. - 12/31/2005 0000950129-06-003398 000-51783 06724923 34 25303
2006-03-16 SC 13G/A sc13g-a_novint.htm 0000912282-06-000232 005-80763 06689511 34 27713
2006-02-21 8-K NOVINT TECHNOLOGIES, INC. 4.01,9.01 0000950129-06-001659 000-51783 06633956 34 22947
2006-02-10 3 MAIN DOCUMENT DESCRIPTION 0001209191-06-009550 6816
2006-02-10 3 MAIN DOCUMENT DESCRIPTION 0001209191-06-009544 3886
2006-02-10 3 MAIN DOCUMENT DESCRIPTION 0001209191-06-009542 7661
2006-02-09 3 MAIN DOCUMENT DESCRIPTION 0001209191-06-008967 6358
2006-02-07 424B3 NOVINT TECHNOLOGIES, INC. - 333-115548 0000950129-06-001093 333-115548 06585999 33 867750
2006-02-06 8-A12G NOVINT TECHNOLOGIES, INC. 0000950129-06-000981 000-51783 06579430 34 11653
2006-01-30 SB-2/A NOVINT TECHNOLOGIES, INC.- AMENDMENT NO.10 - 333-115548 0000950129-06-000769 333-115548 06562875 33 998338
2006-01-18 SB-2/A NOVINT TECHNOLOGIES, INC. - AMENDMENT NO.9 - 333-115548 0000950150-06-000005 333-115548 06536150 33 1309144
2006-01-18 SB-2/A NOVINT TECHNOLOGIES, INC.- AMENDMENT NO.9 - 333-115548 0000950129-06-000348 333-115548 06535062 33 1302828
2005-12-07 SB-2/A NOVINT TECHNOLOGY, INC. - REG. NO. 333-115548 0000950129-05-011679 333-115548 051249048 33 1355556
2005-08-09 SB-2/A REGISTRATION STATEMENT 0001144204-05-024111 333-115548 051007198 33 3887226
2005-05-26 SC 13G sc13g_novinttech.htm 0000912282-05-000348 005-80763 05859479 34 28436
2005-04-08 SB-2/A v015884_sb-2a.txt 0001144204-05-010953 333-115548 05742348 33 29372895
2005-03-15 SB-2/A v014268_sb-2a.txt 0001144204-05-007551 333-115548 05679945 33 467815
2005-02-11 SB-2/A v010594_sb2a.txt 0001144204-05-003982 333-115548 05594736 33 47921648
2005-01-11 SB-2/A v010594_sb2a.txt 0001144204-05-000942 333-115548 05524181 33 32018644
2004-12-29 8-K v010531_8k.txt 9.01 0001144204-04-023081 333-115548 041232570 34 77991
2004-10-15 SB-2/A v07220.txt 0001144204-04-016338 333-115548 041079795 33 498866
2004-07-12 SB-2/A FORM SB-2/A 0001144204-04-009846 333-115548 04910076 339376
2004-05-21 REGDEX/A AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-023735 021-63528 04029996 1688
2004-05-17 SB-2 v03167_sb2.txt 0001144204-04-006718 333-115548 04809517 463445
2004-03-05 REGDEX AUTO-GENERATED PAPER DOCUMENT 06 9999999997-04-008376 021-63528 04009973 1419

Latest XBRL company facts

One latest value per concept from companyfacts (223 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 977.00M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
dei EntityPublicFloat Entity Public Float USD 19.42M 2025-06-30 2025 FY 10-K 2026-02-27 0001213900-26-021201
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 126,543 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 101,206 2022-03-31 2022 Q1 10-Q 2022-05-13 0001387131-22-006134
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 660,843 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 102,986 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 125,951 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001387131-22-011403
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1,360 2021-12-31 2022 FY 10-K 2023-03-31 0001839882-23-008634
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001387131-22-011403
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 850 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 592 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 7,509 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 3,410 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076768
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 60,250 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 56,250 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 720,632 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 714,194 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 185,248 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 281,056 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16,220 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 19.28M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 19.28M 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.26M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112153
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 15,977 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 571,796 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.25M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001387131-22-011403
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 442,224 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 309,869 2025-10-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 442,224 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.74B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap Assets Assets USD 278,207 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap AssetsCurrent Assets, Current USD 261,988 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap Cash Cash USD 228,540 2025-12-31 2025 FY 10-K 2026-02-27 0001213900-26-021201
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 17,966 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.83M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -33,640 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001387131-20-004779
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 25,046 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.98M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -203,494 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 15,463 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.033 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112153
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.27B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10.45M 2023-08-08 S-1/A 2026-09-16 0001213900-26-100567
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 3.25B 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 977.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 977.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap CommonStockValue Common Stock, Value, Issued USD 97,699 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 235,089 2023-08-14 2024 Q3 10-Q 2024-11-14 0001213900-24-098394
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 106.78M 2023-07-05 2025 Q2 10-Q 2025-08-14 0001213900-25-076768
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 2.25M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.87M 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap CreditDerivativeLiquidationProceedsPercentage Credit Derivative, Liquidation Proceeds, Percentage pure 0.18 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 240,000 2023-01-31 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 370,836 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 4.50M 2017-12-31 2019 FY 10-K 2020-05-07 0001387131-20-004506
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 66,837 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 11.28M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 242,905 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 9.95M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 9.90M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.05M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 42,445 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 11.28M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap Depreciation Depreciation USD 3,943 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 751,640 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap DerivativeLiabilities Derivative Liability USD 212,179 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076768
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 992,991 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap DividendsShareBasedCompensationCash Dividend, Share-based Payment Arrangement, Cash USD 14,500 2023-09-15 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001387131-21-011017
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.018 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.02 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.002 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.01 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap EffectiveIncomeTaxRateReconciliationTaxHolidays Effective Income Tax Rate Reconciliation, Tax Holiday, Percent pure 0.5 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -2,492 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 39,171 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -100,490 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 3.06 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD -6,987 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 36,382 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 720,632 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -112,073 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001387131-21-011017
us-gaap IncomeTaxesPaid Income Taxes Paid USD 458 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 75 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-24 0001387131-21-003819
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -44,887 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -1.21M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -51,486 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -534,426 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -6,182 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 25,839 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 41,598 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001839882-23-008634
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -3,456 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001839882-23-008634
us-gaap IncomeTaxReconciliationTaxSettlementsOther Effective Income Tax Rate Reconciliation, Tax Settlement, Other, Amount USD -85,346 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0001387131-22-003894
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -15,094 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -4,434 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001387131-22-011403
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -12,495 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1,360 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001387131-22-006134
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -1,360 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 27,028 2026-01-01 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 368,295 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 472,750 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112153
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 520,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -56,896 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -240,000 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap IncreaseDecreaseInPostemploymentObligations Increase (Decrease) in Postemployment Obligations USD -184 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 26,708 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap IncreaseDecreaseInRoyaltiesPayable Increase (Decrease) in Royalties Payable USD 6,438 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 975.29M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 1.05B 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 184.26M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap InterestExpense Interest Expense USD 14 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-12 0001387131-23-006462
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 16,364 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 14 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap InterestPayableCurrent Interest Payable, Current USD 100,614 2022-03-31 2022 Q1 10-Q 2022-05-13 0001387131-22-006134
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 500 2024-02-07 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.501 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap InvestmentOwnedBalanceShares Investment Owned, Balance, Shares shares 100 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap Liabilities Liabilities USD 4.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 278,207 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 791,232 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap LiabilitiesCurrent Liabilities, Current USD 4.53M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 520,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -70,741 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001387131-21-008428
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 870,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -966 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -351,551 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NotesPayable Notes Payable USD 50,000 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap NotesPayableCurrent Notes Payable, Current USD 300,513 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076768
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap OperatingExpenses Operating Expenses USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 15.70M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 5,595 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap OtherAssets Other Assets USD 5,514 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap OtherAssetsCurrent Other Assets, Current USD 1,549 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap OtherCommitment Other Commitment USD 1.16M 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 992,768 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 210,631 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap OtherNoncashExpense Other Noncash Expense USD 30,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -9,817 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 7,989 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045144
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -8,714 2026-01-01 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 114,100 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 59,027 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap PartnersCapitalAccountPrivatePlacementOfUnits Partners' Capital Account, Private Placement of Units USD 4.65M 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098394
us-gaap PaymentsForFees Payments for Other Fees USD 2,500 2024-02-07 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD 25,849 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098394
us-gaap PaymentsForRepurchaseOfPrivatePlacement Payments for Repurchase of Private Placement USD 3.00M 2021-12-06 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 571,796 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 966 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap PostemploymentBenefitsLiabilityNoncurrent Postemployment Benefits Liability, Noncurrent USD 383 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 12.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 5.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 585 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 236,942 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 30,000 2024-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 34,802 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap PrepaidInsurance Prepaid Insurance USD 40,000 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 870,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 55,000 2024-02-07 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 400,000 2025-09-15 2025 Q3 10-Q 2025-11-18 0001213900-25-112153
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.22M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap ProceedsFromLoans Proceeds from Loans USD 1.10M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112153
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 500,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001213900-25-076768
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 20,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 84,828 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ProductLiabilityContingencyLossExposureNotAccruedBestEstimate Product Liability Contingency, Loss Exposure Not Accrued, Best Estimate USD 520,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap ProductLiabilityContingencyThirdPartyRecoveryPercentage Product Liability Contingency, Third Party Recovery, Percentage pure 0.01 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap ProductWarrantyLiquidationProceedsAmount ProductWarrantyLiquidationProceedsAmount USD 35,814 2024-04-17 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ProductWarrantyLiquidationProceedsPercentage ProductWarrantyLiquidationProceedsPercentage pure 0.01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ProfessionalFees Professional Fees USD 82,534 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001387131-23-009779
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 16,219 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 388,440 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -23.84M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap Revenues Revenues USD 2,568 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0001839882-23-008634
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share ILS/shares 0 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 39,170 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 10.45M 2024-01-01 2024-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 975.29M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.16M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 184.26M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.004 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 21.12M 2024-01-01 2024-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.16M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 184.26M 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.004 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 0.01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.004 2024-01-01 2024-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap SharesHeldInEmployeeStockOptionPlanAllocated Shares Held in Employee Stock Option Plan, Allocated shares 163.14M 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098394
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -4.46M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares shares 9.60M 2022-06-01 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap StockholdersEquityOther Stockholders' Equity, Other USD 773,266 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap StockIssued1 Stock Issued USD 200,000 2026-01-01 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 330.95M 2023-01-01 2023-01-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 200,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.65M 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-20 0001999371-23-000407
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -773,266 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-19 0001213900-25-015289
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 537,197 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-20 0001213900-24-045144
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 0.001 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098394
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.05M 2023-12-31 2023 FY 10-K 2024-04-01 0001213900-24-028793
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 50,000 2025-01-01 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 8,685 2025-12-31 S-1/A 2026-09-16 0001213900-26-100567
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.033 2023-08-08 S-1/A 2026-09-16 0001213900-26-100567
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 520,000 2026-06-30 S-1/A 2026-09-16 0001213900-26-100567
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 2.21B 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-069044
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 976.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 202.31M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001387131-21-011017
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 976.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001213900-26-120701

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →